Deals

Stethoscope and red heart with pink background
Biotech

US VC launches another biotech with China-licensed asset

Aditum is offering up to $1 billion biobucks to Mabwell for exclusive global licensing rights to a dual-target siRNA candidate.
Gabrielle Masson Sep 17, 2025 10:30am
Glowing puzzle piece fitting into puzzle

CSL pays $117M for option on phase 3 blood clotting specialist

Sep 16, 2025 4:31am
glue scissors art supplies

Novartis pens Monte Rosa molecular glue pact worth up to $5.7B

Sep 15, 2025 9:07am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm
A chessboard with blocks that read MA

Novartis spends $1.4B for Tourmaline, CV med that wowed in ph. 2

Sep 9, 2025 4:28am
Racecar speeding down a track

Servier supercharges neuro pipeline with $450M deal

Sep 8, 2025 2:30am